Guardian Pharmacy Services, Inc.
GRDN
$34.09
$1.163.52%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.45B | 1.39B | 1.33B | 1.28B | 1.23B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.45B | 1.39B | 1.33B | 1.28B | 1.23B |
| Cost of Revenue | 1.16B | 1.12B | 1.07B | 1.03B | 984.04M |
| Gross Profit | 292.72M | 274.32M | 260.48M | 253.62M | 244.37M |
| SG&A Expenses | 212.07M | 213.32M | 320.71M | 310.90M | 304.52M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.37B | 1.33B | 1.39B | 1.34B | 1.29B |
| Operating Income | 80.64M | 61.00M | -60.24M | -57.28M | -60.15M |
| Income Before Tax | 73.42M | 58.55M | -63.73M | -57.68M | -66.48M |
| Income Tax Expenses | 24.47M | 19.01M | 12.15M | 8.39M | 4.56M |
| Earnings from Continuing Operations | 48.96 | 39.53 | -75.88 | -66.07 | -71.03 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 261.00K | 705.00K | -6.34M | -11.77M | -16.25M |
| Net Income | 49.22M | 40.24M | -82.22M | -77.84M | -87.29M |
| EBIT | 80.64M | 61.00M | -60.24M | -57.28M | -60.15M |
| EBITDA | 102.98M | 82.74M | -39.33M | -36.99M | -40.38M |
| EPS Basic | 0.79 | 0.28 | -1.72 | -1.64 | -1.80 |
| Normalized Basic EPS | 0.82 | 0.62 | -0.74 | -0.81 | -0.95 |
| EPS Diluted | 0.78 | 0.27 | -1.72 | -1.65 | -1.80 |
| Normalized Diluted EPS | 0.81 | 0.61 | -0.75 | -0.81 | -0.95 |
| Average Basic Shares Outstanding | 249.53M | 248.26M | 247.28M | 246.37M | 184.33M |
| Average Diluted Shares Outstanding | 253.17M | 252.27M | 249.98M | 247.92M | 185.01M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -14.97% | -37.15% | -41.30% |